Carlyle-Zydus, Advent compete for Bharat Serums and Vaccines takeover
Author : Shikha Sinha | Published Date : 2019-04-22
Reports indicate that an association of Zydus Cadila and Carlyle is competing against Advent International, a global private equity group, over the acquisition of Bharat Serums and Vaccines Ltd (BSV), a Mumbai based bio-pharmaceutical company. Both the companies have submitted non-binding offers between Rs 3,450-3,600 crore (US$500-520 million).
The Daftary family, founder promoters of BSV, had supposedly anticipated a valuation of Rs 4,000-4,300 crore (US$600-630 million) for their company. The Daftary family, present investors Orbimed Asia and Kotak Private Equity are seeking to sell a majority stake in the company.
Seemingly, the two funds own a combined 23% stake and the remaining part is with the founders. However, two years ago, the company had planned Rs 2,000-crore initial public offering for giving an exit to the investors, which was called off later.
According to ET reports, in Dec 2017, the company was highly valued at Rs 6,667 crore. If this acquisition agreement goes well, then Daftary would likely retain about 35-40% stake in BSV.
Sources reported that after Heinz India’s buyout, it would be the second time that Zydus Group is looking to work with a PE partner. Zydus Wellness, a profound company of Zydus group, had acquired consumer wellness business of Heinz India including renowned brands like Glucon D and Complan.
For the Rs 4,595-crore acquisition, Zydus had received the support of True North, a PE fund which invested around Rs 1,000 crore.
For the uninitiated, BSV is involved in selling products including antifungals, equine anti-toxins and serums, anaesthetics, cardiovascular and diagnostic products in India and also in over 45 countries. Its R&D facilities run in Germany, India, and the US.
The company also has joint venture-based and own plants in Germany’s Aachen as well as in India at Ahmedabad and Ambernath. In fiscal year 2017, the revenue of the company was Rs 620 crore with a profit of Rs 40 crore, though recent financial details are not available yet.
About Author
Shikha Sinha . .
Shikha Sinha currently pens down content for fractovia.org, a news platform which provides the latest business highlights and industry trends. Shikha also is a contributor on various other online media websites where she writes informative, research-oriented content spanning the retail, healthcare, F&B, and technology sectors. As her first stint in writing, Shikha was an active contributor on Yahoo Voices where she penned down creative and imaginative pieces. She holds a Bachelor of Technology degree in Electrical and Electronics Engineering. She can be contacted at- [email protected] | https://twitter.com/shikhas999
Related News
Clio raises $250 million in a Series D funding by TCV and JMI Equity
The cloud-based legal technology startup hits a historic mark in future of legal industry with this investment. Clio, a leading legal software company has recently announced that it has bagged US$250 million in Series D funding from American equity firms JMI Equity and TCV. According to sour... Read More>>
Co-working firm Spacious the latest in WeWork’s acquisition spree
New York-based co-working business, The We Company, formerly known as WeWork, has today announced its acquisition of rival start-up Spacious. The company, formed three years ago, is focused on converting restaurants closed during the day into efficient spaces for co-working. WeWork is a part of many... Read More>>
SoftBank in talks to invest $150M in Dailyhunt and $400M in Lenskart
SoftBank is expected to lead a $250 million round with private equity major Carlyle for Dailyhunt South American conglomerate Synergy Group also hopes to invest in India’s Jet Airways. SoftBank Group Corp., a Japanese multinational conglomerate, is reportedly in talks to clo... Read More>>